![]() |
Volumn 16, Issue 4, 2009, Pages 558-566
|
Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEMAGGLUTINATION INHIBITING ANTIBODY;
INFLUENZA VACCINE;
ANTIBODY TITER;
ARTICLE;
AVIAN INFLUENZA;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC VALUE;
DRUG APPROVAL;
DRUG EFFICACY;
HEMAGGLUTINATION INHIBITION TEST;
HUMAN;
HUMAN CELL;
IMMUNOGENICITY;
INFLUENZA VIRUS A H5N1;
LICENSING;
PANDEMIC;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
VACCINE PRODUCTION;
ANIMALS;
ANTIBODIES, VIRAL;
DRUG APPROVAL;
ERYTHROCYTES;
HEMAGGLUTINATION INHIBITION TESTS;
HORSES;
HUMANS;
INFLUENZA A VIRUS, H5N1 SUBTYPE;
INFLUENZA VACCINES;
|
EID: 64549129973
PISSN: 15566811
EISSN: 1556679X
Source Type: Journal
DOI: 10.1128/CVI.00368-08 Document Type: Article |
Times cited : (82)
|
References (7)
|